Relationship between P50 suppression and the cortical silent period

NeuroReport

Volumn 18, Issue 14, 2007, Pages 1503-1506

  Möller, Bertram ^a,c   Light, Gregory A ^d   Fitzgerald, Paul B ^f   Snyder, Joel S ^e   Chen, Robert ^b   Daskalakis, Zafiris J ^a,g  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF GREIFSWALD   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f MONASH UNIVERSITY   (Australia)

^g Schizophrenia Program

Author keywords

Cortical inhibition; Cortical silent period; GABA; Neurophysiology; P50 suppression; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; RECEPTOR SUBTYPE;

ADULT; ARTICLE; BRAIN CORTEX; ELECTROENCEPHALOGRAPHY; EVENT RELATED POTENTIAL; FEMALE; GABAERGIC SYSTEM; GABAERGIC TRANSMISSION; HUMAN; MALE; NEUROPHYSIOLOGY; NEUROTRANSMISSION; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR SENSITIVITY; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; CEREBRAL CORTEX; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; EVOKED POTENTIALS, MOTOR; FEMALE; HABITUATION, PSYCHOPHYSIOLOGIC; HUMANS; MALE; NEURAL INHIBITION; STARTLE REACTION; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 34548090189     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e3282ef6a29     Document Type: Article

References (22)

1. Freedman R, Adams CE, Adler LE, Bickford PC, Gault J, Harris JG, et al. Inhibitory neurophysiological deficit as a phenotype for genetic investigation of schizophrenia. Am J Med Genet 2000; 97:58-64.
2. Adler LE, Pachtman E, Franks RD, Pecevich M, Waldo MC, Freedman R. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry 1982; 17:639-654.
3. Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A, Davis A, et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci U S A 1997; 94:587-592.
4. Nakamura H, Kitagawa H, Kawaguchi Y, Tsuji H. Intracortical facilitation and inhibition after transcranial magnetic stimulation in conscious humans. J Physiol 1997; 498:817-823.
5. Kujirai T, Caramia MD, Rothwell JC, Day BL, Thompson PD, Ferbert A, et al. Corticocortical inhibition in human motor cortex. J Physiol (Lond) 1993; 471:501-519.
6. Cantello R, Gianelli M, Civardi C, Mutani R. Magnetic brain stimulation: the silent period after the motor evoked potential. Neurology 1992; 42:1951-1959.
7. Ziemann U, Lonnecker S, Steinhoff BJ, Paulus W. The effect of lorazepam on the motor cortical excitability in man. Exp Brain Res 1996; 109:127-135.
8. Siebner HR, Dressnandt J, Auer C, Conrad B. Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia. Muscle Nerve 1998; 21:1209-1212.
9. Daskalakis ZJ, Christensen BK, Chen R, Fitzgerald PB, Zipursky RB, Kapur S. Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation. Arch Gen Psychiatry 2002; 59:347-354.
10. Daskalakis ZJ, Christensen BK, Fitzgerald PB, Möller BM, Fountain SI, Chen R. Increased cortical inhibition in persons with schizophrenia treated with clozapine. J Psychopharmacol 2006; in press.
11. Adler LE, Olincy A, Cawthra EM, McRae KA, Harris JG, Nagamoto HT, et al. Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients. Am J Psychiatry 2004; 161:1822-1828.
12. Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-IV (SCID). New York: Biometrics Research; 1995.
13. Daskalakis ZJ, Paradiso GO, Christensen BK, Fitzgerald PB, Gunraj C, Chen R. Exploring the connectivity between the cerebellum and motor cortex in humans. J Physiol (Lond) 2004; 557:689-700.
14. Daskalakis ZJ, Molnar GF, Christensen BK, Sailer A, Fitzgerald PB, Chen R. An automated method to determine the transcranial magnetic stimulation-induced contralateral silent period. Clin Neurophysiol 2003; 114:938-944.
15. Light GA, Geyer MA, Clementz BA, Cadenhead KS, Braff DL. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications. Am J Psychiatry 2000; 157:767-771.
16. Daskalakis ZJ, Fountain SI, Chen R. Investigating cortical inhibition as a potential mechanism of atypicality in the antipsychotic clozapine using transcranial magnetic stimulation. In: Nemeroff CB, editors. American College of Neuropsychopharmacology. Waikolao, Hawaii: Nature Publishing Group; 2005.
17. Nagamoto HT, Adler LE, Hea RA, Griffith JM, McRae KA, Freedman R. Gating of auditory P50 in schizophrenics: unique effects of clozapine. Biol Psychiatry 1996; 40:181-188.
18. Oranje B, Gispen-de Wied CC, Verbaten MN, Kahn RS. Modulating sensory gating in healthy volunteers: the effects of ketamine and haloperidol. Biol Psychiatry 2002; 52:887-895.
19. Chen R, Lozano AM, Ashby P. Mechanism of the silent period following transcranial magnetic stimulation. Evidence from epidural recordings. Exp Brain Res 1999; 128:539-542.
20. Weisser R, Weisbrod M, Roehrig M, Rupp A, Schroeder J, Scherg M. Is frontal lobe involved in the generation of auditory evoked P50? NeuroReport 2001; 12:3303-3307.
21. Deisz RA. GABA(B) receptor-mediated effects in human and rat neocortical neurones in vitro. Neuropharmacology 1999; 38:1755-1766.
22. Fuhr P, Agostino R, Hallett M. Spinal motor neuron excitability during the silent period after cortical stimulation. Electroencephalogr Clin Neurophysiol 1991; 81:257-262.